GR3006955T3 - - Google Patents

Info

Publication number
GR3006955T3
GR3006955T3 GR930400212T GR930400212T GR3006955T3 GR 3006955 T3 GR3006955 T3 GR 3006955T3 GR 930400212 T GR930400212 T GR 930400212T GR 930400212 T GR930400212 T GR 930400212T GR 3006955 T3 GR3006955 T3 GR 3006955T3
Authority
GR
Greece
Application number
GR930400212T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888814438A external-priority patent/GB8814438D0/en
Priority claimed from GB888824187A external-priority patent/GB8824187D0/en
Application filed filed Critical
Publication of GR3006955T3 publication Critical patent/GR3006955T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
GR930400212T 1988-06-17 1993-02-02 GR3006955T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888814438A GB8814438D0 (en) 1988-06-17 1988-06-17 Compounds for use in medicine
GB888824187A GB8824187D0 (en) 1988-10-14 1988-10-14 Compounds for use in medicine

Publications (1)

Publication Number Publication Date
GR3006955T3 true GR3006955T3 (cg-RX-API-DMAC10.html) 1993-06-30

Family

ID=26294041

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930400212T GR3006955T3 (cg-RX-API-DMAC10.html) 1988-06-17 1993-02-02

Country Status (12)

Country Link
EP (1) EP0347243B1 (cg-RX-API-DMAC10.html)
JP (1) JPH0240325A (cg-RX-API-DMAC10.html)
KR (1) KR0158870B1 (cg-RX-API-DMAC10.html)
AU (1) AU623147B2 (cg-RX-API-DMAC10.html)
CA (1) CA1327524C (cg-RX-API-DMAC10.html)
DE (1) DE68904358T2 (cg-RX-API-DMAC10.html)
DK (1) DK299089A (cg-RX-API-DMAC10.html)
ES (1) ES2045437T3 (cg-RX-API-DMAC10.html)
GR (1) GR3006955T3 (cg-RX-API-DMAC10.html)
HU (1) HU207220B (cg-RX-API-DMAC10.html)
MY (1) MY106300A (cg-RX-API-DMAC10.html)
PT (1) PT90888B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
CA2056039A1 (en) * 1991-01-22 1992-07-23 Philip L. Fuchs Carbacyclin analogs
US5190972A (en) * 1992-01-27 1993-03-02 The University Of Melbourne Method of combatting cyclosporine organ toxicity with prostaglandin analogs
KR100457499B1 (ko) * 1994-04-12 2005-02-23 도레이 가부시끼가이샤 폐성심질환치료제
JP3783873B2 (ja) * 1994-06-07 2006-06-07 中外製薬株式会社 肺における類線維素形成又は血栓形成に起因する疾患の予防及び治療薬並びに該疾患のモデル動物
EP0759297B1 (en) * 1995-02-27 2006-02-01 Toray Industries, Inc. Remedy for pulmonary heart
CN1224354A (zh) * 1997-02-27 1999-07-28 东丽株式会社 肺循环改善剂
DE60037012T2 (de) 1999-03-18 2008-10-30 Queen Mary And Westfield College Inhibitoren der endothelin-1 synthese
US6521212B1 (en) * 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
PT1426361E (pt) * 1999-10-15 2008-10-08 Sucampo Ag Nova composição contendo um composto bicíclico e um glicérido
ES2347254T3 (es) 2003-12-16 2010-10-27 United Therapeutics Corporation Utilizacion de treprostinil para el tratamiento de las lesiones isquemicas.
US20090124697A1 (en) 2003-12-16 2009-05-14 United Therapeutics Corporation Inhalation formulations of treprostinil
CN102648916A (zh) * 2007-02-09 2012-08-29 联合治疗公司 用于间质性肺病和哮喘的曲前列尼治疗
WO2009033039A2 (en) * 2007-09-07 2009-03-12 United Therapeutics Corporation Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same
US9371264B2 (en) 2013-01-11 2016-06-21 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
US10632129B2 (en) 2014-12-03 2020-04-28 Steadymed Ltd. Preservative-free treprostinil formulations and methods and devices for use with same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA787353B (en) * 1978-05-17 1980-08-27 Wellcome Found Pharmaceutical formulations
DE3006865A1 (de) * 1980-02-23 1981-09-10 Hoechst Ag, 6000 Frankfurt Hetero-imino-prostacycline
US4306075A (en) * 1980-03-28 1981-12-15 The Upjohn Company Composition and process
DE3315356A1 (de) * 1982-04-30 1983-11-17 Ono Pharmaceutical Co. Ltd., Osaka Verwendung von prostaglandinanalogen
JPS61289034A (ja) * 1985-06-17 1986-12-19 Teijin Ltd イソカルバサイクリン類脂肪乳剤
US4820732A (en) * 1985-10-04 1989-04-11 The Upjohn Company Method and compositions for reducing dysfunction in angioplasty procedures

Also Published As

Publication number Publication date
ES2045437T3 (es) 1994-01-16
HUT53524A (en) 1990-11-28
DE68904358T2 (de) 1993-07-29
AU3652889A (en) 1989-12-21
PT90888A (pt) 1989-12-29
DK299089A (da) 1989-12-18
DE68904358D1 (de) 1993-02-25
HU207220B (en) 1993-03-29
AU623147B2 (en) 1992-05-07
EP0347243A1 (en) 1989-12-20
JPH0240325A (ja) 1990-02-09
KR910000158A (ko) 1991-01-29
MY106300A (en) 1995-04-29
DK299089D0 (da) 1989-06-16
KR0158870B1 (ko) 1998-12-01
PT90888B (pt) 1994-12-30
CA1327524C (en) 1994-03-08
EP0347243B1 (en) 1993-01-13

Similar Documents

Publication Publication Date Title
IN176584B (cg-RX-API-DMAC10.html)
GR3006955T3 (cg-RX-API-DMAC10.html)
FR2640926B1 (cg-RX-API-DMAC10.html)
FR2628155B1 (cg-RX-API-DMAC10.html)
DE3922579C2 (cg-RX-API-DMAC10.html)
AU1465288A (cg-RX-API-DMAC10.html)
AU7405187A (cg-RX-API-DMAC10.html)
AU1169888A (cg-RX-API-DMAC10.html)
IN172779B (cg-RX-API-DMAC10.html)
AU1743788A (cg-RX-API-DMAC10.html)
AU2015688A (cg-RX-API-DMAC10.html)
AU7157587A (cg-RX-API-DMAC10.html)
AU1147588A (cg-RX-API-DMAC10.html)
AU7743087A (cg-RX-API-DMAC10.html)
AU7925887A (cg-RX-API-DMAC10.html)
AU8094387A (cg-RX-API-DMAC10.html)
AU8122087A (cg-RX-API-DMAC10.html)
GR2000142Y (cg-RX-API-DMAC10.html)
CH678324A5 (cg-RX-API-DMAC10.html)
BG45184A1 (cg-RX-API-DMAC10.html)
BG45350A1 (cg-RX-API-DMAC10.html)
BG45082A1 (cg-RX-API-DMAC10.html)
BG45114A1 (cg-RX-API-DMAC10.html)
BG45154A1 (cg-RX-API-DMAC10.html)
BG45061A1 (cg-RX-API-DMAC10.html)